Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.295 USD | -0.65% | -5.74% | -45.37% |
05:46pm | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
Apr. 25 | Leerink Partners Downgrades CureVac to Market Perform From Outperform, Sets Price Target at $4 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.37% | 517M | |
+1.99% | 42.59B | |
+8.19% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.77% | 24.81B | |
-24.41% | 18.17B | |
+28.71% | 12.05B | |
-2.67% | 11.7B | |
+6.89% | 11.1B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- CureVac N : Shareholder dievini Files Shareholding Change with US Regulator; Stock Down 5%